Introduction/Overview Griseofulvin represents a significant historical milestone in the development of systemic antifungal therapy. Isolated from the mold Penicillium griseofulvum in 1939, its antifungal properties were not recognized until the late 1950s, when it was introduced as the first orally active agent for the treatment of dermatophyte infections. Despite the subsequent development of newer antifungal … Read more

Introduction/Overview Terbinafine represents a cornerstone agent in the modern pharmacotherapy of superficial fungal infections. As a synthetic allylamine antifungal, it has established a primary role in the management of dermatophytoses, particularly onychomycosis, where its fungicidal activity and favorable pharmacokinetic profile offer distinct therapeutic advantages. The clinical importance of terbinafine is underscored by the high global … Read more

Introduction/Overview Voriconazole represents a cornerstone in the therapeutic armamentarium against invasive fungal infections, a significant cause of morbidity and mortality in immunocompromised patient populations. As a second-generation synthetic triazole antifungal agent, it was developed to address the limitations of earlier azoles, particularly with respect to spectrum of activity and pharmacokinetic properties. Its introduction marked a … Read more

Introduction/Overview Itraconazole represents a cornerstone in the systemic management of a broad spectrum of fungal infections. As a synthetic triazole antifungal agent, its development marked a significant advancement over earlier imidazole derivatives, offering enhanced efficacy, a wider antifungal spectrum, and improved tolerability. The clinical relevance of itraconazole is underscored by its utility in treating both … Read more

Introduction/Overview Nystatin represents a cornerstone antifungal agent within the polyene macrolide class, primarily employed for the management of superficial fungal infections caused by Candida species. Isolated in 1950 from the bacterium Streptomyces noursei, it was the first antifungal polyene discovered and introduced into clinical practice. Its discovery marked a significant advancement in medical mycology, providing … Read more

Introduction/Overview Clofazimine is a synthetic riminophenazine antibiotic with a distinctive profile in antimicrobial chemotherapy. Initially developed in the 1950s for tuberculosis, its primary clinical utility was established in the treatment of leprosy, caused by Mycobacterium leprae. The drug occupies a unique therapeutic niche due to its dual antibacterial and anti-inflammatory properties, which have led to … Read more

Introduction/Overview Neomycin is an aminoglycoside antibiotic derived from Streptomyces fradiae. First isolated in 1949, it has occupied a significant, though increasingly specialized, niche in antimicrobial therapy for over seven decades. Its clinical utility is now largely defined by its pharmacokinetic profile, specifically its minimal systemic absorption when administered via the oral or topical routes, which … Read more

Introduction/Overview Streptomycin, derived from the soil actinomycete Streptomyces griseus, represents the first discovered aminoglycoside antibiotic and a landmark agent in antimicrobial chemotherapy. Its introduction in the mid-20th century provided the first effective pharmacological intervention against tuberculosis, fundamentally altering the prognosis of a disease previously managed largely with sanatorium care. Although its clinical use has diminished … Read more

Introduction/Overview Nitrofurantoin is a synthetic antimicrobial agent with a distinctive chemical structure and a highly specific clinical utility. Since its introduction into clinical practice in the 1950s, it has maintained a significant role in the management of uncomplicated urinary tract infections (UTIs). Its enduring relevance is attributed to a unique mechanism of action, a favorable … Read more

Introduction/Overview Norfloxacin is a synthetic chemotherapeutic agent belonging to the fluoroquinolone class of antibiotics. It represents a significant advancement in antimicrobial therapy, particularly for the management of infections caused by gram-negative bacilli. Developed in the late 1970s and introduced into clinical practice in the 1980s, norfloxacin was among the first broad-spectrum fluoroquinolones, marking a shift … Read more